Transgenomic to Hold Full Year Financial Results Conference Call on April 14, 2016 at 5:00 PM ET

OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Fourth Quarter and Year-End 2015 Financial Results and Business Update Conference Call on Thursday, April 14, 2016 at 5:00 PM ET. The company will present an overview of financial results for the fourth quarter in a press release issued after the market close that day.
To participate in the call, dial 888-632-3381 from the U.S. and Canada, or 785-424-1678 from international locations, and enter conference ID:
TRANS. The call will be webcast live and can be accessed at https://www.webcaster4.com/Webcast/Page/1139/14570, which is also available at the Investor page of Transgenomic’s website.
A replay will be available for two weeks beginning approximately two after the call’s conclusion, until 11:59 PM ET April 28, 2016. To access the replay, dial 800-839-4012 (domestic) or 402-220-2981
(international). The conference call will also be archived at the Investor section of the company’s website.
About Transgenomic, Inc.
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE
COLD-PCR™. Transgenomic also provides specialized clinical and research to biopharmaceutical companies developing targeted therapies. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.